$NDRA

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - Blue Gold (NASDAQ:BGL), BioSig Technologies (NASDAQ:BSGM)

Shares of ENDRA Life Sciences Inc. NDRA rose sharply in pre-market trading after the company announced it will be granted a US patent titled "Radio Frequency Applicator". ENDRA Life Sciences shares jumped 61.4% to $5.58 in the pre-market trading session. Here are some other stocks moving in ...

Original reporting
Benzinga · Avi Kapoor
Published Jul 8, 2025, 10:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2025, 10:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket - Blue Gold (NASDAQ:BGL), BioSig Technologies (NASDAQ:BSGM) — source image
Decision brief

The 30-second read

$NDRABullishMed
01

Why it matters

The patent grant is viewed positively by investors, leading to increased buying interest and a significant pre-market price surge.

02

Market read

The news is highly relevant within the biotech and medical technology sectors, potentially influencing related stocks and sector sentiment.

03

What to watch

Potential delays in patent approval process or commercialization; broader market corrections could offset gains; sector rotation might impact biotech stocks.

Timing: Immediate to short-term (next few days)

Background

ENDRA Life Sciences announced a US patent for 'Radio Frequency Applicator,' a development that could enhance its product portfolio and market competitiveness.

Company-level read

Ticker impact

$NDRABullishHigh confidence
Context

High relevance due to recent patent news and significant pre-market price jump.

Expected impact

Likely short-term upward momentum with potential for continued gains if patent approval translates into commercial success.

Evidence & confidence

The sharp pre-market rise and the significance of patent grants in biotech often lead to sustained investor interest, especially when accompanied by positive news.

Market effects

Potential positive sentiment boost for biotech and life sciences sectors, possibly leading to increased investor interest and funding activities.

Primarily US-focused, with potential ripple effects in global biotech markets due to patent significance.

Limited; impact mostly confined to US biotech sector and related markets.

Counterpoint

The sharp pre-market rise may be an overreaction; profit-taking could lead to a quick reversal, especially if the patent does not translate into immediate commercial benefits.

Key entities

  • ENDRA Life Sciences

    A biotech company focusing on medical imaging and related technologies.

  • US Patent Office

    The authority granting patents, indicating official recognition of intellectual property.

Related articles

$NDRAMed

Noble Africa-ENDRA (NDRA) merger to create pure-play helium and LNG company

ASP Isotopes plans to merge its subsidiary Noble Africa, which holds South Africa’s Renergen helium and LNG project, with ENDRA Life Sciences to form a publicly listed helium platform called Noble Africa. ASP Isotopes expects ~89% ownership post-close. Management cites 1P helium reserves of 7.2 Bcf and targets Phase 1 output of ~70 Mcf/day helium and 2,500 GJ/day LNG, with estimated revenue and cash gross profit. Closing is targeted for Q4, subject to SEC review and approvals.

$ACIMed

Albertsons recalls ready-to-eat items in multiple states amid salmonella-linked jalapeño investigation

Albertsons Companies said it is voluntarily recalling four ready-to-eat products containing jalapeños supplied by Taylor Farms, including items sold at Randalls in Texas. The recall followed a supplier recall tied to an ongoing federal investigation and an FDA probe of a Salmonella Javiana outbreak. FDA reported 345 illnesses in 27 states, 36 hospitalizations, no deaths.

$CMGMed

Salmonella outbreak from Mexican jalapeños reported in 27 U.S. states

U.S. health authorities are investigating a Salmonella outbreak linked to Mexican jalapeño peppers. The CDC and FDA say 345 people are ill across 27 states, with 36 hospitalizations and no deaths. The supplier, Coast Citrus Distributors, recalled peppers sent to restaurants including Chipotle and QDOBA. Chipotle removed jalapeños from some outlets and shares fell over 8% on Aug. 4.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).